<p><sup>a</sup> The definitions of CLL, SLL and MBL are from the international workshop on CLL [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0137232#pone.0137232.ref018" target="_blank">18</a>].</p><p>Summary of CLL patient characteristics <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0137232#t001fn001" target="_blank"><sup>a</sup></a>.</p
<p>(a) Characteristics of CLL patients and control group. (b) Percentages of plasmablasts and serum ...
Chronic lymphocytic leukemia (CLL) shows a remarkable clinical heterogeneity: there are some patient...
<p>p, CLL/SLL diagnosis post-nephropathy; Cs, corticosteroids; R-FC, rituximab+fludarabine+cyclophos...
<p>A – the group of 43 patients analyzed by qRT-PCR for PD-1, PD-L1 and their splicing variants.</p>...
<p>MBC: monoclonal B-cells clone.</p><p>* median and range.</p><p>** Positive (>30%).</p><p>Clinical...
<p>*for definition, see ref <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.00...
<p>* in the peripheral blood</p><p>Characteristics of chronic lymphocytic leukemia (CLL) patients an...
<p>Summary of the prognosis factors considered in the clinic and genetic lesions that the ten patien...
<p>* Manifestations are defined according to American College of Rheumatology’s 1982 revised criteri...
Chronic lymphocytic leukemia (CLL) is a frequentCD5+ B-cell neoplasia that involves peripheralblood,...
Patient characteristics of LCL patients on IL SSG treatment, Boru Meda General Hospital, 2021.</p
<p>Baseline characteristics of the patients. <a href="http://www.plosone.org/article/info:doi/10.137...
<p>Characteristics of patients in each cohort<a href="http://www.plosone.org/article/info:doi/10.137...
<p>AML = acute myeloid leukemia; ALL = acute lymphoblastic leukemia; CLL = chronic lymphocytic leuke...
<p>Abbreviations: ALL, acute lymphatic leukemia; AML, acute myeloid leukemia; MDS, myelodysplastic s...
<p>(a) Characteristics of CLL patients and control group. (b) Percentages of plasmablasts and serum ...
Chronic lymphocytic leukemia (CLL) shows a remarkable clinical heterogeneity: there are some patient...
<p>p, CLL/SLL diagnosis post-nephropathy; Cs, corticosteroids; R-FC, rituximab+fludarabine+cyclophos...
<p>A – the group of 43 patients analyzed by qRT-PCR for PD-1, PD-L1 and their splicing variants.</p>...
<p>MBC: monoclonal B-cells clone.</p><p>* median and range.</p><p>** Positive (>30%).</p><p>Clinical...
<p>*for definition, see ref <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.00...
<p>* in the peripheral blood</p><p>Characteristics of chronic lymphocytic leukemia (CLL) patients an...
<p>Summary of the prognosis factors considered in the clinic and genetic lesions that the ten patien...
<p>* Manifestations are defined according to American College of Rheumatology’s 1982 revised criteri...
Chronic lymphocytic leukemia (CLL) is a frequentCD5+ B-cell neoplasia that involves peripheralblood,...
Patient characteristics of LCL patients on IL SSG treatment, Boru Meda General Hospital, 2021.</p
<p>Baseline characteristics of the patients. <a href="http://www.plosone.org/article/info:doi/10.137...
<p>Characteristics of patients in each cohort<a href="http://www.plosone.org/article/info:doi/10.137...
<p>AML = acute myeloid leukemia; ALL = acute lymphoblastic leukemia; CLL = chronic lymphocytic leuke...
<p>Abbreviations: ALL, acute lymphatic leukemia; AML, acute myeloid leukemia; MDS, myelodysplastic s...
<p>(a) Characteristics of CLL patients and control group. (b) Percentages of plasmablasts and serum ...
Chronic lymphocytic leukemia (CLL) shows a remarkable clinical heterogeneity: there are some patient...
<p>p, CLL/SLL diagnosis post-nephropathy; Cs, corticosteroids; R-FC, rituximab+fludarabine+cyclophos...